Navigation Links
Einstein & Montefiore present research at American Diabetes Association Scientific Sessions
Date:6/9/2014

June 9, 2014 (BRONX, NY) Investigators at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center will present their latest research at the American Diabetes Association's 74th Scientific Sessions. Einstein-Montefiore scientists and clinicians are participating in nearly three dozen presentations, sessions and symposia during the five-day meeting. They will address a range of basic, translational and clinical research topicsfrom medication adherence in adolescents and the impact on resveratrol and vitamin D on insulin resistance to epigenetic and genetic triggers for the disease. ADA will takes place June 13-17 at the Moscone Center in San Francisco, California.

Among the highlights are symposia featuring:

  • Jill Crandall, M.D., professor of clinical medicine at Einstein and attending physician, endocrinology at Montefiore, on the most recent findings from the ongoing Diabetes Prevention Program Outcomes Study (Mon., June 16 at 8:00 a.m.)

  • Maureen Charron, Ph.D., professor of biochemistry at Einstein, on the role of glucagon in metabolic homeostasis (Fri., June 13 at 2:00 p.m.)

  • Rajat Singh, M.D., assistant professor of medicine at Einstein, on the role of autophagy in diabetes (Sat., June 14 at 2:15 p.m.)

  • Judith Wylie-Rosett, Ed.D., division head, health promotion and nutrition research, department of epidemiology and population health at Einstein, on better approaches to counseling weight loss among obese patients (Tues., June 17 at 7:30 a.m.)

Poster and oral presentations will include:

  • Vitamin D Repletion Reduces Adipose Tissue Fibrosis and Improves Insulin. Oral presentation by Akankasha Goyal, M.D., a research fellow in the lab of Meredith Hawkins, M.D., professor of medicine at Einstein and attending physician, endocrinology at Montefiore. Abstract #OR-90, IA-OR02: Adipose Tissue Development and Metabolic Signaling. Sat., June 14, 8:00-10:00 a.m. W-2002 (West Building)

  • Distress and Diabetes Treatment Adherence: A Mediating Role for Perceived Control in Adults with Type 2 Diabetes. Poster presented by Jeffrey S. Gonzalez, Ph.D., assistant professor of medicine and epidemiology & population heath at Einstein. Poster #822, GPS01: Saturday General Poster Session. Sat., June 14, 11:30 a.m.-1:30 p.m. Poster Hall (Hall D-North)

  • Resveratrol Improves Insulin Resistance without Affecting Muscle Mitochondria in Overweight Humans. Oral presentation by Roger Maginley, M.D., a research fellow in the lab of Dr. Hawkins. Abstract #144, AC-OR05: Hypoglycemia Brain, Muscle, Heart and Opioids. Sun., June 15, 8:00-10:00 a.m., N-132 (North Building)

  • Relationship of Self-Esteem to Glycemic Control amongst Minority Adolescents with Type 1 Diabetes. Poster presented by Joslyn Kenowitz, Ph.D. student in lab of Dr. Gonzalez, working in collaboration with Rubina Heptulla, M.B.B.S., chief of pediatric endocrinology at Einstein and Montefiore. Poster #64-LB, Late Breaking Poster Session. Sun., June 15, 12:00-2:00 p.m., Poster Hall (Hall D-North)

  • Exposure to a Maternal High Fat Milieu Alters Hepatic and White Adipose Epigenome in Mice. Poster presented by Maureen Charron, Ph.D., professor of biochemistry at Einstein. Poster #1806, GPS03: Monday General Poster Session. Mon., June 16, 12:00-2:00 p.m., Poster Hall (Hall D-North).

  • FTO Genetic Variants, Dietary Intakes, and Adiposity: Results from Over 16,000 Children and Adolescents. Oral presentation by Qibin Qi, Ph.D., assistant professor of epidemiology and population health at Einstein. Abstract #382-OR, CT-OR14: ADA Presidents Oral Session. Tues., June 17, 9:45-11:45 a.m., N-134 (North Building)

Einstein-Montefiore investigators are available to speak about their research and other topics of interest upon request.


'/>"/>

Contact: Deirdre Branley
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related medicine news :

1. Feinstein Institute researcher publishes new perspective on sepsis
2. Einstein helps establish $28 million consortium to find ebola treatment
3. Registration open for the Weinstein Cardiovascular Conference
4. Feinstein Institute Researcher Joins International Partnership in Neuroscience Research
5. Feinstein Institute researchers show a genetic overlap in schizophrenia and cognitive ability
6. Feinstein Researcher Receives 2013 Best of Manhasset Award
7. Feinstein Institute Encourages Science Education for NY Area Middle and High School Students
8. Einstein researchers lead panels at NIH Aging and Chronic Disease Symposium on Geroscience
9. How does aging affect cancer? Einstein awarded $2.8m grant to answer NCI provocative question
10. Albert Einstein Cancer Center begins 40th year of continuous NIH support with $17 million grant
11. Feinstein Institute Researcher Organizes LI Alzheimer’s Consortium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of ... ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership in ... It also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
Breaking Medicine Technology: